Carbapenem-resistant Escherichia coli carrying the blaVIM-1 gene in the community

International Journal of Antimicrobial Agents

Volumn 34, Issue 2, 2009, Pages 187-188

  Vitti, Danai ^a   Protonotariou, Efthimia ^a   Sofianou, Danae ^a  

^a Department of Clinical Microbiology   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE VIM 1; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; COLISTIN; ERTAPENEM; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ASPERGILLUS NIGER; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CASE REPORT; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HUMAN; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; COMMUNITY-ACQUIRED INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MALE;

EID: 67349100954     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.02.011     Document Type: Letter

References (6)

1. Queenan A.M., and Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 20 (2007) 440-458
2. Tsakris A., Ikonomidis A., Poulou A., Spanakis N., Pournaras S., and Markou F. Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-β-lactamase. J Antimicrob Chemother 60 (2007) 136-139
3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. Document M100-S17. Wayne, PA: CLSI; 2007.
4. Yan J.J., Hsueh P.R., Ko W.C., Luh K.T., Tsai S.H., Wu H.M., et al. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 45 (2001) 2224-2228
5. Rodríguez-Baño J., Navarro M.D., Romero L., Martínez-Martínez L., Muniain M.A., Perea E.J., et al. Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42 (2004) 1089-1094
6. Colodner R., Rock W., Chazan B., Keller N., Guy N., Sakran W., et al. Risk factors for the development of extended-spectrum β-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 23 (2004) 163-167